Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003 Pharmaceutical Investing
Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA Pharmaceutical Investing
BriaCell to Present Clinical and Scientific Data at International Cancer Immunotherapy and The MicroCap Conferences Biotech Investing
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine Pharmaceutical Investing
Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Medical Device Investing
Applied DNA Subsidiary, LineaRx Signs Joint Development Agreement with Takis and Evvivax Genetics Investing
Galectin Therapeutics Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA Biotech Investing
Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD Cannabis Investing News
